PORCILIS ERY+PARVO
PORCILIS ERY+PARVO
Authorised
- Porcine parvovirus, strain 014, Inactivated
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
Product identification
Medicine name:
ПОРЦИЛИС ЕРИ+ПАРВО
PORCILIS ERY+PARVO
Active substance:
- Porcine parvovirus, strain 014, Inactivated
- Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine parvovirus, strain 014, Inactivated552.00/European Pharmacopoeia Unit(s)1.00Dose
-
Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated50.00/international unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Intervet S.A.
Responsible authority:
- Bulgarian Agency For Food Safety
Authorisation number:
- 0022-2021
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 30/01/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 30/01/2024
How useful was this page?:
